Recurve Capital's Deep Dive into Carvana's Performance
Money

Recurve Capital's Deep Dive into Carvana's Performance

authorBy Chika Uwazie
DateJul 03, 2026
Read Time3 min
Recurve Capital provides an in-depth analysis of its investment in Carvana, highlighting the company's recent stock performance and its impact on the fund's overall returns. The report delves into Carvana's financial trajectory, past successes, and future outlook, offering insights into Recurve Capital's long-term investment philosophy.

Unpacking Carvana: A Detailed Look at Investment Performance and Future Prospects

Recurve Capital's Mid-Year Financial Review and Carvana's Impact

Recurve Capital recently disseminated its investor letter for June 2026, which revealed a notable underperformance of its portfolio for the year. This downturn was primarily driven by Carvana (CVNA), a key holding, whose stock experienced a 10% decline in June and a 22% drop year-to-date through June 30th. This significant decrease in Carvana's value accounted for nearly 80% of the portfolio's negative returns for the year. In June, Recurve Capital Partners recorded a gross return of -4.3% and a net return of -4.4%, starkly contrasting with the S&P 500 Index's -1.1% and the Nasdaq's -2.8% during the same period. The firm encourages investors to examine its top five holdings for 2026 to understand its strategic allocations.

Carvana's Market Position and Recent Financials

In its second-quarter 2026 investor correspondence, Recurve Capital specifically addressed Carvana Co. (NYSE: CVNA), a prominent US-based online used car retailer. As of July 2, 2026, Carvana's shares closed at $68.60. The company saw a one-month return of 3.14%, although its shares had depreciated by 1.53% over the preceding 52 weeks. Carvana Co. currently commands a market capitalization of $75.24 billion.

Recurve Capital's Perspective on Carvana's Volatility

Recurve Capital acknowledged the considerable underperformance in 2026, explaining that while other portfolio components saw mixed results, Carvana's 10% dip in June was the primary driver of negative returns, offsetting gains elsewhere. The firm emphasized its intent to use Carvana as a practical illustration of its long-term return generation strategy, applicable across its entire portfolio. Carvana's 22% year-to-date decline through June 30th has been the main contributor to the portfolio's negative performance. The company's significant position within the portfolio exacerbated the impact, leading to a performance that lagged indices by over 3,000 basis points in the first half of 2026.

The Evolution of Carvana's Financial Health and Investor Returns

Recurve Capital noted that Carvana had previously delivered substantial positive returns when its cash flow shifted from a negative state in 2021 and 2022 to a robust positive position in 2023, 2024, and 2025. Currently, in 2026, owner earnings continue to show substantial growth. Consensus EBITDA estimates for Carvana are projected to rise significantly, from $600 million in early 2023 to approximately $3 billion today. This optimistic forecast reflects the firm's proxy for owner earnings. This financial turnaround, especially from a highly leveraged situation, propelled the stock from under $2 in early 2023 to approximately $65, representing an astounding 33-fold return on a five-fold increase in expectations.

Carvana's Presence in Hedge Fund Portfolios and Alternative Investment Opportunities

Carvana Co. (NYSE: CVNA) was not included in Recurve Capital's compilation of the 40 most popular stocks among hedge funds at the close of 2026. Data indicates that 79 hedge fund portfolios held Carvana Co. at the end of the first quarter, a decrease from 100 in the previous quarter. In Q1 2026, Carvana Co. reported revenue of $6.432 billion, representing a 52% increase from Q1 2025. While recognizing Carvana's investment potential, Recurve Capital suggests that certain AI stocks may offer higher upside potential with reduced downside risk, particularly for those looking for undervalued AI opportunities that could benefit from current economic trends.

More Articles
Money
Structure Therapeutics: A Promising Biotech Investment Opportunity
Structure Therapeutics (GPCR) is attracting significant attention as a potential high-growth biotech stock. Analysts have issued 'Buy' ratings, citing strong clinical trial results for their weight-loss drug, aleniglipron. This oral treatment shows efficacy in weight reduction and offers broader health benefits, positioning it as a leading candidate in the expanding obesity management market.
By T. Harv EkerJul 03, 2026
Money
Bitmine Immersion Nears 5% Ethereum Ownership Goal, Bolstered by Strong Financials and AI Demand
Bitmine Immersion Technologies Inc. (BMNR) is on the verge of achieving a 5% stake in Ethereum's total supply, holding 5.62 million ETH valued at approximately $9.7 billion. The company recently declared a cash dividend for its preferred shareholders, highlighting its robust financial health. Chairman Tom Lee attributes the growing demand for neutral public blockchains like Ethereum to advancements in AI systems. BMNR, operating as a blockchain technology firm, specializes in ETH treasury operations and digital asset ecosystem services.
By Natalie PaceJul 03, 2026
Money
Navigating Retirement Withdrawals: The Impact of RMDs and Tax Bracket Changes
A 73-year-old with a $1.4 million traditional IRA faces a mandatory $53,000 Required Minimum Distribution (RMD), pushing single filers into a higher tax bracket and potentially incurring Medicare surcharges. Qualified Charitable Distributions (QCDs) can help satisfy RMDs without increasing Adjusted Gross Income, offering a strategic approach to mitigate tax implications.
By Mr. Money MustacheJul 03, 2026
Money
Valuation Concerns Lead Vltava Fund to Divest Applied Materials (AMAT)
Vltava Fund, a value-oriented investment firm, revealed in its Q2 2026 investor letter that it sold its position in Applied Materials, Inc. (AMAT) due to valuation concerns. Despite acknowledging AMAT as an excellent business crucial to the semiconductor industry, the fund cited high price-to-sales and price-to-earnings ratios, coupled with the cyclical nature of the semiconductor market, as reasons for the divestment. They emphasized that at such elevated valuations, the margin of safety for investors was diminished.
By Bola SokunbiJul 03, 2026
Money
Vltava Fund Divests KLA Corporation Amid Valuation Concerns
Vltava Fund, a prominent investment management firm, has announced its decision to divest its holdings in KLA Corporation (KLAC) during the second quarter of 2026. This move was primarily driven by an unfavorable balance between the company's robust quality and its escalating market valuation. The fund emphasized that despite KLA's integral role in the semiconductor industry, its stock price had reached levels that presented an unsustainable risk-reward profile for investors. This strategic exit underscores Vltava Fund's adherence to fundamental investment principles, prioritizing a margin of safety over potential future growth in an increasingly cyclical market.
By Scott PapeJul 03, 2026